Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
16.9.2021
0:00
34:49
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
Weitere Episoden von „JAMA Oncology Author Interviews“
Verpasse keine Episode von “JAMA Oncology Author Interviews” und abonniere ihn in der kostenlosen GetPodcast App.